"We are thrilled to introduce the EchoLUTION FFPE RNA Kit to the scientific community," declares Dr. Thomas Neumann, Chief Commercial Officer & President of BioEcho, Inc. "This innovative solution not only simplifies the RNA extraction process but also delivers superior quality RNA for downstream applications. We believe that this kit will significantly enhance researchers‘ ability to study diseases and contribute to advancements in the field of molecular biology."
FFPE tissue samples are an invaluable data source for disease research. However, their analysis poses significant challenges due to the fixation and preservation procedures involved. Traditional workflows have been tedious, time-consuming, and often require the use of hazardous reagents. Unlike traditional methods, which involve lengthy incubations and multiple steps, the EchoLUTION FFPE RNA Kit allows for RNA extraction in a single step after tissue decrosslinking and paraffin removal. This not only saves valuable time but allows the RNA flowing through the purification matrix untouched, making the process more streamlined and user-friendly.
BioEcho Life Sciences is a specialized solution provider for the extraction and analysis of nucleic acids. We create disruptive technologies, products, and workflows that make downstream processing of nucleic acids easier and faster, significantly increase throughput, and deliver reliable results. Our patented EchoLUTION™ technology enables the fastest DNA and RNA extraction on the market – in just one single step. It reduces the associated plastic consumption by up to 70 %.
BioEcho was founded in 2016 by leading industry experts. The headquarter in Cologne, Germany, is certified according to ISO 9001 and ISO 13485.
BioEcho. The Nucleic Acid Experts.
BioEcho Life Sciences GmbH
Nattermannallee 1
50829 Köln
Telefon: +49 221 998897 0
http://www.bioecho.de/
Scientific Communications Manager
Telefon: +49 221 998897-24
E-Mail: laura.torres.benito@bioecho.de
